Global Phage Therapy Market Research Report 2024(Status and Outlook)
Report Overview:
Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature, and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.
The Global Phage Therapy Market Size was estimated at USD 38.19 million in 2023 and is projected to reach USD 101.01 million by 2029, exhibiting a CAGR of 17.60% during the forecast period.
This report provides a deep insight into the global Phage Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Phage Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Phage Therapy market in any manner.
Global Phage Therapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
NPO Microgen
Proteon Pharmaceuticals
Phagelux
Intralytix
Micreos
Eliava BioPreparations
Locus Biosciences,Inc
Pharmex Group,LLC
Pherecydes Pharma
APS Biocontrol Ltd. (APS)
Qingdao Phagepharm Bio-tech
Fixed-Phage Limited
Zeptometrix
Phage International, Inc.
MicroMir
iNtODEWORLD, Inc.
NEXTBIOTICS
Armata Pharmaceuticals, Inc.
Innophage
Adaptive Phage Therapeutics
TechnoPhage
Market Segmentation (by Type)
DsDNA Bacteriophage
SsDNA Bacteriophage
SsRNA Bacteriophage
Others
Market Segmentation (by Application)
Animal Health
Aquaculture
Agriculture
Food Industry
Human Health
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Phage Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature, and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.
The Global Phage Therapy Market Size was estimated at USD 38.19 million in 2023 and is projected to reach USD 101.01 million by 2029, exhibiting a CAGR of 17.60% during the forecast period.
This report provides a deep insight into the global Phage Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Phage Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Phage Therapy market in any manner.
Global Phage Therapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
NPO Microgen
Proteon Pharmaceuticals
Phagelux
Intralytix
Micreos
Eliava BioPreparations
Locus Biosciences,Inc
Pharmex Group,LLC
Pherecydes Pharma
APS Biocontrol Ltd. (APS)
Qingdao Phagepharm Bio-tech
Fixed-Phage Limited
Zeptometrix
Phage International, Inc.
MicroMir
iNtODEWORLD, Inc.
NEXTBIOTICS
Armata Pharmaceuticals, Inc.
Innophage
Adaptive Phage Therapeutics
TechnoPhage
Market Segmentation (by Type)
DsDNA Bacteriophage
SsDNA Bacteriophage
SsRNA Bacteriophage
Others
Market Segmentation (by Application)
Animal Health
Aquaculture
Agriculture
Food Industry
Human Health
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Phage Therapy Market
- Overview of the regional outlook of the Phage Therapy Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Phage Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Phage Therapy
1.2 Key Market Segments
1.2.1 Phage Therapy Segment by Type
1.2.2 Phage Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PHAGE THERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Phage Therapy Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Phage Therapy Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PHAGE THERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Global Phage Therapy Sales by Manufacturers (2019-2024)
3.2 Global Phage Therapy Revenue Market Share by Manufacturers (2019-2024)
3.3 Phage Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Phage Therapy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Phage Therapy Sales Sites, Area Served, Product Type
3.6 Phage Therapy Market Competitive Situation and Trends
3.6.1 Phage Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Phage Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PHAGE THERAPY INDUSTRY CHAIN ANALYSIS
4.1 Phage Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PHAGE THERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PHAGE THERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Phage Therapy Sales Market Share by Type (2019-2024)
6.3 Global Phage Therapy Market Size Market Share by Type (2019-2024)
6.4 Global Phage Therapy Price by Type (2019-2024)
7 PHAGE THERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Phage Therapy Market Sales by Application (2019-2024)
7.3 Global Phage Therapy Market Size (M USD) by Application (2019-2024)
7.4 Global Phage Therapy Sales Growth Rate by Application (2019-2024)
8 PHAGE THERAPY MARKET SEGMENTATION BY REGION
8.1 Global Phage Therapy Sales by Region
8.1.1 Global Phage Therapy Sales by Region
8.1.2 Global Phage Therapy Sales Market Share by Region
8.2 North America
8.2.1 North America Phage Therapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Phage Therapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Phage Therapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Phage Therapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Phage Therapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 NPO Microgen
9.1.1 NPO Microgen Phage Therapy Basic Information
9.1.2 NPO Microgen Phage Therapy Product Overview
9.1.3 NPO Microgen Phage Therapy Product Market Performance
9.1.4 NPO Microgen Business Overview
9.1.5 NPO Microgen Phage Therapy SWOT Analysis
9.1.6 NPO Microgen Recent Developments
9.2 Proteon Pharmaceuticals
9.2.1 Proteon Pharmaceuticals Phage Therapy Basic Information
9.2.2 Proteon Pharmaceuticals Phage Therapy Product Overview
9.2.3 Proteon Pharmaceuticals Phage Therapy Product Market Performance
9.2.4 Proteon Pharmaceuticals Business Overview
9.2.5 Proteon Pharmaceuticals Phage Therapy SWOT Analysis
9.2.6 Proteon Pharmaceuticals Recent Developments
9.3 Phagelux
9.3.1 Phagelux Phage Therapy Basic Information
9.3.2 Phagelux Phage Therapy Product Overview
9.3.3 Phagelux Phage Therapy Product Market Performance
9.3.4 Phagelux Phage Therapy SWOT Analysis
9.3.5 Phagelux Business Overview
9.3.6 Phagelux Recent Developments
9.4 Intralytix
9.4.1 Intralytix Phage Therapy Basic Information
9.4.2 Intralytix Phage Therapy Product Overview
9.4.3 Intralytix Phage Therapy Product Market Performance
9.4.4 Intralytix Business Overview
9.4.5 Intralytix Recent Developments
9.5 Micreos
9.5.1 Micreos Phage Therapy Basic Information
9.5.2 Micreos Phage Therapy Product Overview
9.5.3 Micreos Phage Therapy Product Market Performance
9.5.4 Micreos Business Overview
9.5.5 Micreos Recent Developments
9.6 Eliava BioPreparations
9.6.1 Eliava BioPreparations Phage Therapy Basic Information
9.6.2 Eliava BioPreparations Phage Therapy Product Overview
9.6.3 Eliava BioPreparations Phage Therapy Product Market Performance
9.6.4 Eliava BioPreparations Business Overview
9.6.5 Eliava BioPreparations Recent Developments
9.7 Locus Biosciences,Inc
9.7.1 Locus Biosciences,Inc Phage Therapy Basic Information
9.7.2 Locus Biosciences,Inc Phage Therapy Product Overview
9.7.3 Locus Biosciences,Inc Phage Therapy Product Market Performance
9.7.4 Locus Biosciences,Inc Business Overview
9.7.5 Locus Biosciences,Inc Recent Developments
9.8 Pharmex Group,LLC
9.8.1 Pharmex Group,LLC Phage Therapy Basic Information
9.8.2 Pharmex Group,LLC Phage Therapy Product Overview
9.8.3 Pharmex Group,LLC Phage Therapy Product Market Performance
9.8.4 Pharmex Group,LLC Business Overview
9.8.5 Pharmex Group,LLC Recent Developments
9.9 Pherecydes Pharma
9.9.1 Pherecydes Pharma Phage Therapy Basic Information
9.9.2 Pherecydes Pharma Phage Therapy Product Overview
9.9.3 Pherecydes Pharma Phage Therapy Product Market Performance
9.9.4 Pherecydes Pharma Business Overview
9.9.5 Pherecydes Pharma Recent Developments
9.10 APS Biocontrol Ltd. (APS)
9.10.1 APS Biocontrol Ltd. (APS) Phage Therapy Basic Information
9.10.2 APS Biocontrol Ltd. (APS) Phage Therapy Product Overview
9.10.3 APS Biocontrol Ltd. (APS) Phage Therapy Product Market Performance
9.10.4 APS Biocontrol Ltd. (APS) Business Overview
9.10.5 APS Biocontrol Ltd. (APS) Recent Developments
9.11 Qingdao Phagepharm Bio-tech
9.11.1 Qingdao Phagepharm Bio-tech Phage Therapy Basic Information
9.11.2 Qingdao Phagepharm Bio-tech Phage Therapy Product Overview
9.11.3 Qingdao Phagepharm Bio-tech Phage Therapy Product Market Performance
9.11.4 Qingdao Phagepharm Bio-tech Business Overview
9.11.5 Qingdao Phagepharm Bio-tech Recent Developments
9.12 Fixed-Phage Limited
9.12.1 Fixed-Phage Limited Phage Therapy Basic Information
9.12.2 Fixed-Phage Limited Phage Therapy Product Overview
9.12.3 Fixed-Phage Limited Phage Therapy Product Market Performance
9.12.4 Fixed-Phage Limited Business Overview
9.12.5 Fixed-Phage Limited Recent Developments
9.13 Zeptometrix
9.13.1 Zeptometrix Phage Therapy Basic Information
9.13.2 Zeptometrix Phage Therapy Product Overview
9.13.3 Zeptometrix Phage Therapy Product Market Performance
9.13.4 Zeptometrix Business Overview
9.13.5 Zeptometrix Recent Developments
9.14 Phage International, Inc.
9.14.1 Phage International, Inc. Phage Therapy Basic Information
9.14.2 Phage International, Inc. Phage Therapy Product Overview
9.14.3 Phage International, Inc. Phage Therapy Product Market Performance
9.14.4 Phage International, Inc. Business Overview
9.14.5 Phage International, Inc. Recent Developments
9.15 MicroMir
9.15.1 MicroMir Phage Therapy Basic Information
9.15.2 MicroMir Phage Therapy Product Overview
9.15.3 MicroMir Phage Therapy Product Market Performance
9.15.4 MicroMir Business Overview
9.15.5 MicroMir Recent Developments
9.16 iNtODEWORLD, Inc.
9.16.1 iNtODEWORLD, Inc. Phage Therapy Basic Information
9.16.2 iNtODEWORLD, Inc. Phage Therapy Product Overview
9.16.3 iNtODEWORLD, Inc. Phage Therapy Product Market Performance
9.16.4 iNtODEWORLD, Inc. Business Overview
9.16.5 iNtODEWORLD, Inc. Recent Developments
9.17 NEXTBIOTICS
9.17.1 NEXTBIOTICS Phage Therapy Basic Information
9.17.2 NEXTBIOTICS Phage Therapy Product Overview
9.17.3 NEXTBIOTICS Phage Therapy Product Market Performance
9.17.4 NEXTBIOTICS Business Overview
9.17.5 NEXTBIOTICS Recent Developments
9.18 Armata Pharmaceuticals, Inc.
9.18.1 Armata Pharmaceuticals, Inc. Phage Therapy Basic Information
9.18.2 Armata Pharmaceuticals, Inc. Phage Therapy Product Overview
9.18.3 Armata Pharmaceuticals, Inc. Phage Therapy Product Market Performance
9.18.4 Armata Pharmaceuticals, Inc. Business Overview
9.18.5 Armata Pharmaceuticals, Inc. Recent Developments
9.19 Innophage
9.19.1 Innophage Phage Therapy Basic Information
9.19.2 Innophage Phage Therapy Product Overview
9.19.3 Innophage Phage Therapy Product Market Performance
9.19.4 Innophage Business Overview
9.19.5 Innophage Recent Developments
9.20 Adaptive Phage Therapeutics
9.20.1 Adaptive Phage Therapeutics Phage Therapy Basic Information
9.20.2 Adaptive Phage Therapeutics Phage Therapy Product Overview
9.20.3 Adaptive Phage Therapeutics Phage Therapy Product Market Performance
9.20.4 Adaptive Phage Therapeutics Business Overview
9.20.5 Adaptive Phage Therapeutics Recent Developments
9.21 TechnoPhage
9.21.1 TechnoPhage Phage Therapy Basic Information
9.21.2 TechnoPhage Phage Therapy Product Overview
9.21.3 TechnoPhage Phage Therapy Product Market Performance
9.21.4 TechnoPhage Business Overview
9.21.5 TechnoPhage Recent Developments
10 PHAGE THERAPY MARKET FORECAST BY REGION
10.1 Global Phage Therapy Market Size Forecast
10.2 Global Phage Therapy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Phage Therapy Market Size Forecast by Country
10.2.3 Asia Pacific Phage Therapy Market Size Forecast by Region
10.2.4 South America Phage Therapy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Phage Therapy by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Phage Therapy Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Phage Therapy by Type (2025-2030)
11.1.2 Global Phage Therapy Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Phage Therapy by Type (2025-2030)
11.2 Global Phage Therapy Market Forecast by Application (2025-2030)
11.2.1 Global Phage Therapy Sales (K Units) Forecast by Application
11.2.2 Global Phage Therapy Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Phage Therapy
1.2 Key Market Segments
1.2.1 Phage Therapy Segment by Type
1.2.2 Phage Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PHAGE THERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Phage Therapy Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Phage Therapy Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PHAGE THERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Global Phage Therapy Sales by Manufacturers (2019-2024)
3.2 Global Phage Therapy Revenue Market Share by Manufacturers (2019-2024)
3.3 Phage Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Phage Therapy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Phage Therapy Sales Sites, Area Served, Product Type
3.6 Phage Therapy Market Competitive Situation and Trends
3.6.1 Phage Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Phage Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PHAGE THERAPY INDUSTRY CHAIN ANALYSIS
4.1 Phage Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PHAGE THERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PHAGE THERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Phage Therapy Sales Market Share by Type (2019-2024)
6.3 Global Phage Therapy Market Size Market Share by Type (2019-2024)
6.4 Global Phage Therapy Price by Type (2019-2024)
7 PHAGE THERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Phage Therapy Market Sales by Application (2019-2024)
7.3 Global Phage Therapy Market Size (M USD) by Application (2019-2024)
7.4 Global Phage Therapy Sales Growth Rate by Application (2019-2024)
8 PHAGE THERAPY MARKET SEGMENTATION BY REGION
8.1 Global Phage Therapy Sales by Region
8.1.1 Global Phage Therapy Sales by Region
8.1.2 Global Phage Therapy Sales Market Share by Region
8.2 North America
8.2.1 North America Phage Therapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Phage Therapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Phage Therapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Phage Therapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Phage Therapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 NPO Microgen
9.1.1 NPO Microgen Phage Therapy Basic Information
9.1.2 NPO Microgen Phage Therapy Product Overview
9.1.3 NPO Microgen Phage Therapy Product Market Performance
9.1.4 NPO Microgen Business Overview
9.1.5 NPO Microgen Phage Therapy SWOT Analysis
9.1.6 NPO Microgen Recent Developments
9.2 Proteon Pharmaceuticals
9.2.1 Proteon Pharmaceuticals Phage Therapy Basic Information
9.2.2 Proteon Pharmaceuticals Phage Therapy Product Overview
9.2.3 Proteon Pharmaceuticals Phage Therapy Product Market Performance
9.2.4 Proteon Pharmaceuticals Business Overview
9.2.5 Proteon Pharmaceuticals Phage Therapy SWOT Analysis
9.2.6 Proteon Pharmaceuticals Recent Developments
9.3 Phagelux
9.3.1 Phagelux Phage Therapy Basic Information
9.3.2 Phagelux Phage Therapy Product Overview
9.3.3 Phagelux Phage Therapy Product Market Performance
9.3.4 Phagelux Phage Therapy SWOT Analysis
9.3.5 Phagelux Business Overview
9.3.6 Phagelux Recent Developments
9.4 Intralytix
9.4.1 Intralytix Phage Therapy Basic Information
9.4.2 Intralytix Phage Therapy Product Overview
9.4.3 Intralytix Phage Therapy Product Market Performance
9.4.4 Intralytix Business Overview
9.4.5 Intralytix Recent Developments
9.5 Micreos
9.5.1 Micreos Phage Therapy Basic Information
9.5.2 Micreos Phage Therapy Product Overview
9.5.3 Micreos Phage Therapy Product Market Performance
9.5.4 Micreos Business Overview
9.5.5 Micreos Recent Developments
9.6 Eliava BioPreparations
9.6.1 Eliava BioPreparations Phage Therapy Basic Information
9.6.2 Eliava BioPreparations Phage Therapy Product Overview
9.6.3 Eliava BioPreparations Phage Therapy Product Market Performance
9.6.4 Eliava BioPreparations Business Overview
9.6.5 Eliava BioPreparations Recent Developments
9.7 Locus Biosciences,Inc
9.7.1 Locus Biosciences,Inc Phage Therapy Basic Information
9.7.2 Locus Biosciences,Inc Phage Therapy Product Overview
9.7.3 Locus Biosciences,Inc Phage Therapy Product Market Performance
9.7.4 Locus Biosciences,Inc Business Overview
9.7.5 Locus Biosciences,Inc Recent Developments
9.8 Pharmex Group,LLC
9.8.1 Pharmex Group,LLC Phage Therapy Basic Information
9.8.2 Pharmex Group,LLC Phage Therapy Product Overview
9.8.3 Pharmex Group,LLC Phage Therapy Product Market Performance
9.8.4 Pharmex Group,LLC Business Overview
9.8.5 Pharmex Group,LLC Recent Developments
9.9 Pherecydes Pharma
9.9.1 Pherecydes Pharma Phage Therapy Basic Information
9.9.2 Pherecydes Pharma Phage Therapy Product Overview
9.9.3 Pherecydes Pharma Phage Therapy Product Market Performance
9.9.4 Pherecydes Pharma Business Overview
9.9.5 Pherecydes Pharma Recent Developments
9.10 APS Biocontrol Ltd. (APS)
9.10.1 APS Biocontrol Ltd. (APS) Phage Therapy Basic Information
9.10.2 APS Biocontrol Ltd. (APS) Phage Therapy Product Overview
9.10.3 APS Biocontrol Ltd. (APS) Phage Therapy Product Market Performance
9.10.4 APS Biocontrol Ltd. (APS) Business Overview
9.10.5 APS Biocontrol Ltd. (APS) Recent Developments
9.11 Qingdao Phagepharm Bio-tech
9.11.1 Qingdao Phagepharm Bio-tech Phage Therapy Basic Information
9.11.2 Qingdao Phagepharm Bio-tech Phage Therapy Product Overview
9.11.3 Qingdao Phagepharm Bio-tech Phage Therapy Product Market Performance
9.11.4 Qingdao Phagepharm Bio-tech Business Overview
9.11.5 Qingdao Phagepharm Bio-tech Recent Developments
9.12 Fixed-Phage Limited
9.12.1 Fixed-Phage Limited Phage Therapy Basic Information
9.12.2 Fixed-Phage Limited Phage Therapy Product Overview
9.12.3 Fixed-Phage Limited Phage Therapy Product Market Performance
9.12.4 Fixed-Phage Limited Business Overview
9.12.5 Fixed-Phage Limited Recent Developments
9.13 Zeptometrix
9.13.1 Zeptometrix Phage Therapy Basic Information
9.13.2 Zeptometrix Phage Therapy Product Overview
9.13.3 Zeptometrix Phage Therapy Product Market Performance
9.13.4 Zeptometrix Business Overview
9.13.5 Zeptometrix Recent Developments
9.14 Phage International, Inc.
9.14.1 Phage International, Inc. Phage Therapy Basic Information
9.14.2 Phage International, Inc. Phage Therapy Product Overview
9.14.3 Phage International, Inc. Phage Therapy Product Market Performance
9.14.4 Phage International, Inc. Business Overview
9.14.5 Phage International, Inc. Recent Developments
9.15 MicroMir
9.15.1 MicroMir Phage Therapy Basic Information
9.15.2 MicroMir Phage Therapy Product Overview
9.15.3 MicroMir Phage Therapy Product Market Performance
9.15.4 MicroMir Business Overview
9.15.5 MicroMir Recent Developments
9.16 iNtODEWORLD, Inc.
9.16.1 iNtODEWORLD, Inc. Phage Therapy Basic Information
9.16.2 iNtODEWORLD, Inc. Phage Therapy Product Overview
9.16.3 iNtODEWORLD, Inc. Phage Therapy Product Market Performance
9.16.4 iNtODEWORLD, Inc. Business Overview
9.16.5 iNtODEWORLD, Inc. Recent Developments
9.17 NEXTBIOTICS
9.17.1 NEXTBIOTICS Phage Therapy Basic Information
9.17.2 NEXTBIOTICS Phage Therapy Product Overview
9.17.3 NEXTBIOTICS Phage Therapy Product Market Performance
9.17.4 NEXTBIOTICS Business Overview
9.17.5 NEXTBIOTICS Recent Developments
9.18 Armata Pharmaceuticals, Inc.
9.18.1 Armata Pharmaceuticals, Inc. Phage Therapy Basic Information
9.18.2 Armata Pharmaceuticals, Inc. Phage Therapy Product Overview
9.18.3 Armata Pharmaceuticals, Inc. Phage Therapy Product Market Performance
9.18.4 Armata Pharmaceuticals, Inc. Business Overview
9.18.5 Armata Pharmaceuticals, Inc. Recent Developments
9.19 Innophage
9.19.1 Innophage Phage Therapy Basic Information
9.19.2 Innophage Phage Therapy Product Overview
9.19.3 Innophage Phage Therapy Product Market Performance
9.19.4 Innophage Business Overview
9.19.5 Innophage Recent Developments
9.20 Adaptive Phage Therapeutics
9.20.1 Adaptive Phage Therapeutics Phage Therapy Basic Information
9.20.2 Adaptive Phage Therapeutics Phage Therapy Product Overview
9.20.3 Adaptive Phage Therapeutics Phage Therapy Product Market Performance
9.20.4 Adaptive Phage Therapeutics Business Overview
9.20.5 Adaptive Phage Therapeutics Recent Developments
9.21 TechnoPhage
9.21.1 TechnoPhage Phage Therapy Basic Information
9.21.2 TechnoPhage Phage Therapy Product Overview
9.21.3 TechnoPhage Phage Therapy Product Market Performance
9.21.4 TechnoPhage Business Overview
9.21.5 TechnoPhage Recent Developments
10 PHAGE THERAPY MARKET FORECAST BY REGION
10.1 Global Phage Therapy Market Size Forecast
10.2 Global Phage Therapy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Phage Therapy Market Size Forecast by Country
10.2.3 Asia Pacific Phage Therapy Market Size Forecast by Region
10.2.4 South America Phage Therapy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Phage Therapy by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Phage Therapy Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Phage Therapy by Type (2025-2030)
11.1.2 Global Phage Therapy Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Phage Therapy by Type (2025-2030)
11.2 Global Phage Therapy Market Forecast by Application (2025-2030)
11.2.1 Global Phage Therapy Sales (K Units) Forecast by Application
11.2.2 Global Phage Therapy Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Phage Therapy Market Size Comparison by Region (M USD)
Table 5. Global Phage Therapy Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Phage Therapy Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Phage Therapy Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Phage Therapy Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phage Therapy as of 2022)
Table 10. Global Market Phage Therapy Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Phage Therapy Sales Sites and Area Served
Table 12. Manufacturers Phage Therapy Product Type
Table 13. Global Phage Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Phage Therapy
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Phage Therapy Market Challenges
Table 22. Global Phage Therapy Sales by Type (K Units)
Table 23. Global Phage Therapy Market Size by Type (M USD)
Table 24. Global Phage Therapy Sales (K Units) by Type (2019-2024)
Table 25. Global Phage Therapy Sales Market Share by Type (2019-2024)
Table 26. Global Phage Therapy Market Size (M USD) by Type (2019-2024)
Table 27. Global Phage Therapy Market Size Share by Type (2019-2024)
Table 28. Global Phage Therapy Price (USD/Unit) by Type (2019-2024)
Table 29. Global Phage Therapy Sales (K Units) by Application
Table 30. Global Phage Therapy Market Size by Application
Table 31. Global Phage Therapy Sales by Application (2019-2024) & (K Units)
Table 32. Global Phage Therapy Sales Market Share by Application (2019-2024)
Table 33. Global Phage Therapy Sales by Application (2019-2024) & (M USD)
Table 34. Global Phage Therapy Market Share by Application (2019-2024)
Table 35. Global Phage Therapy Sales Growth Rate by Application (2019-2024)
Table 36. Global Phage Therapy Sales by Region (2019-2024) & (K Units)
Table 37. Global Phage Therapy Sales Market Share by Region (2019-2024)
Table 38. North America Phage Therapy Sales by Country (2019-2024) & (K Units)
Table 39. Europe Phage Therapy Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Phage Therapy Sales by Region (2019-2024) & (K Units)
Table 41. South America Phage Therapy Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Phage Therapy Sales by Region (2019-2024) & (K Units)
Table 43. NPO Microgen Phage Therapy Basic Information
Table 44. NPO Microgen Phage Therapy Product Overview
Table 45. NPO Microgen Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. NPO Microgen Business Overview
Table 47. NPO Microgen Phage Therapy SWOT Analysis
Table 48. NPO Microgen Recent Developments
Table 49. Proteon Pharmaceuticals Phage Therapy Basic Information
Table 50. Proteon Pharmaceuticals Phage Therapy Product Overview
Table 51. Proteon Pharmaceuticals Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Proteon Pharmaceuticals Business Overview
Table 53. Proteon Pharmaceuticals Phage Therapy SWOT Analysis
Table 54. Proteon Pharmaceuticals Recent Developments
Table 55. Phagelux Phage Therapy Basic Information
Table 56. Phagelux Phage Therapy Product Overview
Table 57. Phagelux Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Phagelux Phage Therapy SWOT Analysis
Table 59. Phagelux Business Overview
Table 60. Phagelux Recent Developments
Table 61. Intralytix Phage Therapy Basic Information
Table 62. Intralytix Phage Therapy Product Overview
Table 63. Intralytix Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Intralytix Business Overview
Table 65. Intralytix Recent Developments
Table 66. Micreos Phage Therapy Basic Information
Table 67. Micreos Phage Therapy Product Overview
Table 68. Micreos Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Micreos Business Overview
Table 70. Micreos Recent Developments
Table 71. Eliava BioPreparations Phage Therapy Basic Information
Table 72. Eliava BioPreparations Phage Therapy Product Overview
Table 73. Eliava BioPreparations Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Eliava BioPreparations Business Overview
Table 75. Eliava BioPreparations Recent Developments
Table 76. Locus Biosciences,Inc Phage Therapy Basic Information
Table 77. Locus Biosciences,Inc Phage Therapy Product Overview
Table 78. Locus Biosciences,Inc Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Locus Biosciences,Inc Business Overview
Table 80. Locus Biosciences,Inc Recent Developments
Table 81. Pharmex Group,LLC Phage Therapy Basic Information
Table 82. Pharmex Group,LLC Phage Therapy Product Overview
Table 83. Pharmex Group,LLC Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Pharmex Group,LLC Business Overview
Table 85. Pharmex Group,LLC Recent Developments
Table 86. Pherecydes Pharma Phage Therapy Basic Information
Table 87. Pherecydes Pharma Phage Therapy Product Overview
Table 88. Pherecydes Pharma Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Pherecydes Pharma Business Overview
Table 90. Pherecydes Pharma Recent Developments
Table 91. APS Biocontrol Ltd. (APS) Phage Therapy Basic Information
Table 92. APS Biocontrol Ltd. (APS) Phage Therapy Product Overview
Table 93. APS Biocontrol Ltd. (APS) Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. APS Biocontrol Ltd. (APS) Business Overview
Table 95. APS Biocontrol Ltd. (APS) Recent Developments
Table 96. Qingdao Phagepharm Bio-tech Phage Therapy Basic Information
Table 97. Qingdao Phagepharm Bio-tech Phage Therapy Product Overview
Table 98. Qingdao Phagepharm Bio-tech Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Qingdao Phagepharm Bio-tech Business Overview
Table 100. Qingdao Phagepharm Bio-tech Recent Developments
Table 101. Fixed-Phage Limited Phage Therapy Basic Information
Table 102. Fixed-Phage Limited Phage Therapy Product Overview
Table 103. Fixed-Phage Limited Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Fixed-Phage Limited Business Overview
Table 105. Fixed-Phage Limited Recent Developments
Table 106. Zeptometrix Phage Therapy Basic Information
Table 107. Zeptometrix Phage Therapy Product Overview
Table 108. Zeptometrix Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Zeptometrix Business Overview
Table 110. Zeptometrix Recent Developments
Table 111. Phage International, Inc. Phage Therapy Basic Information
Table 112. Phage International, Inc. Phage Therapy Product Overview
Table 113. Phage International, Inc. Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Phage International, Inc. Business Overview
Table 115. Phage International, Inc. Recent Developments
Table 116. MicroMir Phage Therapy Basic Information
Table 117. MicroMir Phage Therapy Product Overview
Table 118. MicroMir Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. MicroMir Business Overview
Table 120. MicroMir Recent Developments
Table 121. iNtODEWORLD, Inc. Phage Therapy Basic Information
Table 122. iNtODEWORLD, Inc. Phage Therapy Product Overview
Table 123. iNtODEWORLD, Inc. Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. iNtODEWORLD, Inc. Business Overview
Table 125. iNtODEWORLD, Inc. Recent Developments
Table 126. NEXTBIOTICS Phage Therapy Basic Information
Table 127. NEXTBIOTICS Phage Therapy Product Overview
Table 128. NEXTBIOTICS Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. NEXTBIOTICS Business Overview
Table 130. NEXTBIOTICS Recent Developments
Table 131. Armata Pharmaceuticals, Inc. Phage Therapy Basic Information
Table 132. Armata Pharmaceuticals, Inc. Phage Therapy Product Overview
Table 133. Armata Pharmaceuticals, Inc. Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Armata Pharmaceuticals, Inc. Business Overview
Table 135. Armata Pharmaceuticals, Inc. Recent Developments
Table 136. Innophage Phage Therapy Basic Information
Table 137. Innophage Phage Therapy Product Overview
Table 138. Innophage Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. Innophage Business Overview
Table 140. Innophage Recent Developments
Table 141. Adaptive Phage Therapeutics Phage Therapy Basic Information
Table 142. Adaptive Phage Therapeutics Phage Therapy Product Overview
Table 143. Adaptive Phage Therapeutics Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 144. Adaptive Phage Therapeutics Business Overview
Table 145. Adaptive Phage Therapeutics Recent Developments
Table 146. TechnoPhage Phage Therapy Basic Information
Table 147. TechnoPhage Phage Therapy Product Overview
Table 148. TechnoPhage Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 149. TechnoPhage Business Overview
Table 150. TechnoPhage Recent Developments
Table 151. Global Phage Therapy Sales Forecast by Region (2025-2030) & (K Units)
Table 152. Global Phage Therapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 153. North America Phage Therapy Sales Forecast by Country (2025-2030) & (K Units)
Table 154. North America Phage Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 155. Europe Phage Therapy Sales Forecast by Country (2025-2030) & (K Units)
Table 156. Europe Phage Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 157. Asia Pacific Phage Therapy Sales Forecast by Region (2025-2030) & (K Units)
Table 158. Asia Pacific Phage Therapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 159. South America Phage Therapy Sales Forecast by Country (2025-2030) & (K Units)
Table 160. South America Phage Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 161. Middle East and Africa Phage Therapy Consumption Forecast by Country (2025-2030) & (Units)
Table 162. Middle East and Africa Phage Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 163. Global Phage Therapy Sales Forecast by Type (2025-2030) & (K Units)
Table 164. Global Phage Therapy Market Size Forecast by Type (2025-2030) & (M USD)
Table 165. Global Phage Therapy Price Forecast by Type (2025-2030) & (USD/Unit)
Table 166. Global Phage Therapy Sales (K Units) Forecast by Application (2025-2030)
Table 167. Global Phage Therapy Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Phage Therapy Market Size Comparison by Region (M USD)
Table 5. Global Phage Therapy Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Phage Therapy Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Phage Therapy Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Phage Therapy Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phage Therapy as of 2022)
Table 10. Global Market Phage Therapy Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Phage Therapy Sales Sites and Area Served
Table 12. Manufacturers Phage Therapy Product Type
Table 13. Global Phage Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Phage Therapy
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Phage Therapy Market Challenges
Table 22. Global Phage Therapy Sales by Type (K Units)
Table 23. Global Phage Therapy Market Size by Type (M USD)
Table 24. Global Phage Therapy Sales (K Units) by Type (2019-2024)
Table 25. Global Phage Therapy Sales Market Share by Type (2019-2024)
Table 26. Global Phage Therapy Market Size (M USD) by Type (2019-2024)
Table 27. Global Phage Therapy Market Size Share by Type (2019-2024)
Table 28. Global Phage Therapy Price (USD/Unit) by Type (2019-2024)
Table 29. Global Phage Therapy Sales (K Units) by Application
Table 30. Global Phage Therapy Market Size by Application
Table 31. Global Phage Therapy Sales by Application (2019-2024) & (K Units)
Table 32. Global Phage Therapy Sales Market Share by Application (2019-2024)
Table 33. Global Phage Therapy Sales by Application (2019-2024) & (M USD)
Table 34. Global Phage Therapy Market Share by Application (2019-2024)
Table 35. Global Phage Therapy Sales Growth Rate by Application (2019-2024)
Table 36. Global Phage Therapy Sales by Region (2019-2024) & (K Units)
Table 37. Global Phage Therapy Sales Market Share by Region (2019-2024)
Table 38. North America Phage Therapy Sales by Country (2019-2024) & (K Units)
Table 39. Europe Phage Therapy Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Phage Therapy Sales by Region (2019-2024) & (K Units)
Table 41. South America Phage Therapy Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Phage Therapy Sales by Region (2019-2024) & (K Units)
Table 43. NPO Microgen Phage Therapy Basic Information
Table 44. NPO Microgen Phage Therapy Product Overview
Table 45. NPO Microgen Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. NPO Microgen Business Overview
Table 47. NPO Microgen Phage Therapy SWOT Analysis
Table 48. NPO Microgen Recent Developments
Table 49. Proteon Pharmaceuticals Phage Therapy Basic Information
Table 50. Proteon Pharmaceuticals Phage Therapy Product Overview
Table 51. Proteon Pharmaceuticals Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Proteon Pharmaceuticals Business Overview
Table 53. Proteon Pharmaceuticals Phage Therapy SWOT Analysis
Table 54. Proteon Pharmaceuticals Recent Developments
Table 55. Phagelux Phage Therapy Basic Information
Table 56. Phagelux Phage Therapy Product Overview
Table 57. Phagelux Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Phagelux Phage Therapy SWOT Analysis
Table 59. Phagelux Business Overview
Table 60. Phagelux Recent Developments
Table 61. Intralytix Phage Therapy Basic Information
Table 62. Intralytix Phage Therapy Product Overview
Table 63. Intralytix Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Intralytix Business Overview
Table 65. Intralytix Recent Developments
Table 66. Micreos Phage Therapy Basic Information
Table 67. Micreos Phage Therapy Product Overview
Table 68. Micreos Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Micreos Business Overview
Table 70. Micreos Recent Developments
Table 71. Eliava BioPreparations Phage Therapy Basic Information
Table 72. Eliava BioPreparations Phage Therapy Product Overview
Table 73. Eliava BioPreparations Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Eliava BioPreparations Business Overview
Table 75. Eliava BioPreparations Recent Developments
Table 76. Locus Biosciences,Inc Phage Therapy Basic Information
Table 77. Locus Biosciences,Inc Phage Therapy Product Overview
Table 78. Locus Biosciences,Inc Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Locus Biosciences,Inc Business Overview
Table 80. Locus Biosciences,Inc Recent Developments
Table 81. Pharmex Group,LLC Phage Therapy Basic Information
Table 82. Pharmex Group,LLC Phage Therapy Product Overview
Table 83. Pharmex Group,LLC Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Pharmex Group,LLC Business Overview
Table 85. Pharmex Group,LLC Recent Developments
Table 86. Pherecydes Pharma Phage Therapy Basic Information
Table 87. Pherecydes Pharma Phage Therapy Product Overview
Table 88. Pherecydes Pharma Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Pherecydes Pharma Business Overview
Table 90. Pherecydes Pharma Recent Developments
Table 91. APS Biocontrol Ltd. (APS) Phage Therapy Basic Information
Table 92. APS Biocontrol Ltd. (APS) Phage Therapy Product Overview
Table 93. APS Biocontrol Ltd. (APS) Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. APS Biocontrol Ltd. (APS) Business Overview
Table 95. APS Biocontrol Ltd. (APS) Recent Developments
Table 96. Qingdao Phagepharm Bio-tech Phage Therapy Basic Information
Table 97. Qingdao Phagepharm Bio-tech Phage Therapy Product Overview
Table 98. Qingdao Phagepharm Bio-tech Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Qingdao Phagepharm Bio-tech Business Overview
Table 100. Qingdao Phagepharm Bio-tech Recent Developments
Table 101. Fixed-Phage Limited Phage Therapy Basic Information
Table 102. Fixed-Phage Limited Phage Therapy Product Overview
Table 103. Fixed-Phage Limited Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Fixed-Phage Limited Business Overview
Table 105. Fixed-Phage Limited Recent Developments
Table 106. Zeptometrix Phage Therapy Basic Information
Table 107. Zeptometrix Phage Therapy Product Overview
Table 108. Zeptometrix Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Zeptometrix Business Overview
Table 110. Zeptometrix Recent Developments
Table 111. Phage International, Inc. Phage Therapy Basic Information
Table 112. Phage International, Inc. Phage Therapy Product Overview
Table 113. Phage International, Inc. Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Phage International, Inc. Business Overview
Table 115. Phage International, Inc. Recent Developments
Table 116. MicroMir Phage Therapy Basic Information
Table 117. MicroMir Phage Therapy Product Overview
Table 118. MicroMir Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. MicroMir Business Overview
Table 120. MicroMir Recent Developments
Table 121. iNtODEWORLD, Inc. Phage Therapy Basic Information
Table 122. iNtODEWORLD, Inc. Phage Therapy Product Overview
Table 123. iNtODEWORLD, Inc. Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. iNtODEWORLD, Inc. Business Overview
Table 125. iNtODEWORLD, Inc. Recent Developments
Table 126. NEXTBIOTICS Phage Therapy Basic Information
Table 127. NEXTBIOTICS Phage Therapy Product Overview
Table 128. NEXTBIOTICS Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. NEXTBIOTICS Business Overview
Table 130. NEXTBIOTICS Recent Developments
Table 131. Armata Pharmaceuticals, Inc. Phage Therapy Basic Information
Table 132. Armata Pharmaceuticals, Inc. Phage Therapy Product Overview
Table 133. Armata Pharmaceuticals, Inc. Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Armata Pharmaceuticals, Inc. Business Overview
Table 135. Armata Pharmaceuticals, Inc. Recent Developments
Table 136. Innophage Phage Therapy Basic Information
Table 137. Innophage Phage Therapy Product Overview
Table 138. Innophage Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. Innophage Business Overview
Table 140. Innophage Recent Developments
Table 141. Adaptive Phage Therapeutics Phage Therapy Basic Information
Table 142. Adaptive Phage Therapeutics Phage Therapy Product Overview
Table 143. Adaptive Phage Therapeutics Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 144. Adaptive Phage Therapeutics Business Overview
Table 145. Adaptive Phage Therapeutics Recent Developments
Table 146. TechnoPhage Phage Therapy Basic Information
Table 147. TechnoPhage Phage Therapy Product Overview
Table 148. TechnoPhage Phage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 149. TechnoPhage Business Overview
Table 150. TechnoPhage Recent Developments
Table 151. Global Phage Therapy Sales Forecast by Region (2025-2030) & (K Units)
Table 152. Global Phage Therapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 153. North America Phage Therapy Sales Forecast by Country (2025-2030) & (K Units)
Table 154. North America Phage Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 155. Europe Phage Therapy Sales Forecast by Country (2025-2030) & (K Units)
Table 156. Europe Phage Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 157. Asia Pacific Phage Therapy Sales Forecast by Region (2025-2030) & (K Units)
Table 158. Asia Pacific Phage Therapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 159. South America Phage Therapy Sales Forecast by Country (2025-2030) & (K Units)
Table 160. South America Phage Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 161. Middle East and Africa Phage Therapy Consumption Forecast by Country (2025-2030) & (Units)
Table 162. Middle East and Africa Phage Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 163. Global Phage Therapy Sales Forecast by Type (2025-2030) & (K Units)
Table 164. Global Phage Therapy Market Size Forecast by Type (2025-2030) & (M USD)
Table 165. Global Phage Therapy Price Forecast by Type (2025-2030) & (USD/Unit)
Table 166. Global Phage Therapy Sales (K Units) Forecast by Application (2025-2030)
Table 167. Global Phage Therapy Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Phage Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Phage Therapy Market Size (M USD), 2019-2030
Figure 5. Global Phage Therapy Market Size (M USD) (2019-2030)
Figure 6. Global Phage Therapy Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Phage Therapy Market Size by Country (M USD)
Figure 11. Phage Therapy Sales Share by Manufacturers in 2023
Figure 12. Global Phage Therapy Revenue Share by Manufacturers in 2023
Figure 13. Phage Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Phage Therapy Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Phage Therapy Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Phage Therapy Market Share by Type
Figure 18. Sales Market Share of Phage Therapy by Type (2019-2024)
Figure 19. Sales Market Share of Phage Therapy by Type in 2023
Figure 20. Market Size Share of Phage Therapy by Type (2019-2024)
Figure 21. Market Size Market Share of Phage Therapy by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Phage Therapy Market Share by Application
Figure 24. Global Phage Therapy Sales Market Share by Application (2019-2024)
Figure 25. Global Phage Therapy Sales Market Share by Application in 2023
Figure 26. Global Phage Therapy Market Share by Application (2019-2024)
Figure 27. Global Phage Therapy Market Share by Application in 2023
Figure 28. Global Phage Therapy Sales Growth Rate by Application (2019-2024)
Figure 29. Global Phage Therapy Sales Market Share by Region (2019-2024)
Figure 30. North America Phage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Phage Therapy Sales Market Share by Country in 2023
Figure 32. U.S. Phage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Phage Therapy Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Phage Therapy Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Phage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Phage Therapy Sales Market Share by Country in 2023
Figure 37. Germany Phage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Phage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Phage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Phage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Phage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Phage Therapy Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Phage Therapy Sales Market Share by Region in 2023
Figure 44. China Phage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Phage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Phage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Phage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Phage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Phage Therapy Sales and Growth Rate (K Units)
Figure 50. South America Phage Therapy Sales Market Share by Country in 2023
Figure 51. Brazil Phage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Phage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Phage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Phage Therapy Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Phage Therapy Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Phage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Phage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Phage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Phage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Phage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Phage Therapy Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Phage Therapy Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Phage Therapy Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Phage Therapy Market Share Forecast by Type (2025-2030)
Figure 65. Global Phage Therapy Sales Forecast by Application (2025-2030)
Figure 66. Global Phage Therapy Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Phage Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Phage Therapy Market Size (M USD), 2019-2030
Figure 5. Global Phage Therapy Market Size (M USD) (2019-2030)
Figure 6. Global Phage Therapy Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Phage Therapy Market Size by Country (M USD)
Figure 11. Phage Therapy Sales Share by Manufacturers in 2023
Figure 12. Global Phage Therapy Revenue Share by Manufacturers in 2023
Figure 13. Phage Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Phage Therapy Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Phage Therapy Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Phage Therapy Market Share by Type
Figure 18. Sales Market Share of Phage Therapy by Type (2019-2024)
Figure 19. Sales Market Share of Phage Therapy by Type in 2023
Figure 20. Market Size Share of Phage Therapy by Type (2019-2024)
Figure 21. Market Size Market Share of Phage Therapy by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Phage Therapy Market Share by Application
Figure 24. Global Phage Therapy Sales Market Share by Application (2019-2024)
Figure 25. Global Phage Therapy Sales Market Share by Application in 2023
Figure 26. Global Phage Therapy Market Share by Application (2019-2024)
Figure 27. Global Phage Therapy Market Share by Application in 2023
Figure 28. Global Phage Therapy Sales Growth Rate by Application (2019-2024)
Figure 29. Global Phage Therapy Sales Market Share by Region (2019-2024)
Figure 30. North America Phage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Phage Therapy Sales Market Share by Country in 2023
Figure 32. U.S. Phage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Phage Therapy Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Phage Therapy Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Phage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Phage Therapy Sales Market Share by Country in 2023
Figure 37. Germany Phage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Phage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Phage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Phage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Phage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Phage Therapy Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Phage Therapy Sales Market Share by Region in 2023
Figure 44. China Phage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Phage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Phage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Phage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Phage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Phage Therapy Sales and Growth Rate (K Units)
Figure 50. South America Phage Therapy Sales Market Share by Country in 2023
Figure 51. Brazil Phage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Phage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Phage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Phage Therapy Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Phage Therapy Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Phage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Phage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Phage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Phage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Phage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Phage Therapy Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Phage Therapy Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Phage Therapy Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Phage Therapy Market Share Forecast by Type (2025-2030)
Figure 65. Global Phage Therapy Sales Forecast by Application (2025-2030)
Figure 66. Global Phage Therapy Market Share Forecast by Application (2025-2030)
